Fulminant Liver Failure due to Hepatitis B Reactivation During Treatment With Tocilizumab

Tocilizumab is a humanized monoclonal antibody targeting the interleukin-6 receptor that is frequently used for the treatment of refractory rheumatoid arthritis. Since patients with hepatitis B virus (HBV) infection were excluded from pivotal trials, the risk of HBV reactivation with this novel drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Sonneveld, Milan J., Murad, S. Darwish, van der Eijk, A.A., de Man, R.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946203/
https://www.ncbi.nlm.nih.gov/pubmed/32042838
http://dx.doi.org/10.14309/crj.0000000000000243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946203/
https://www.ncbi.nlm.nih.gov/pubmed/32042838
http://dx.doi.org/10.14309/crj.0000000000000243

Ejemplares similares